TD Cowen Lowers Colgate-Palmolive (NYSE:CL) Price Target to $100.00

Colgate-Palmolive (NYSE:CL) had its price objective cut by equities research analysts at TD Cowen from $110.00 to $100.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. TD Cowen’s price target would indicate a potential upside of 14.68% from the company’s current price.

Other analysts have also recently issued reports about the stock. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Wednesday, January 1st. Piper Sandler lowered their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price target for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday. Finally, JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $103.63.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock traded down $0.19 during trading hours on Wednesday, reaching $87.20. 1,428,512 shares of the stock traded hands, compared to its average volume of 3,702,811. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The firm has a market capitalization of $71.24 billion, a price-to-earnings ratio of 24.99, a P/E/G ratio of 3.31 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company has a 50 day moving average price of $93.03 and a 200 day moving average price of $98.31.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.34% of the stock is currently owned by insiders.

Institutional Trading of Colgate-Palmolive

A number of institutional investors have recently modified their holdings of CL. D Orazio & Associates Inc. lifted its position in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after acquiring an additional 108 shares during the last quarter. Fiducient Advisors LLC increased its position in Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after buying an additional 110 shares in the last quarter. Wealthspire Advisors LLC raised its stake in Colgate-Palmolive by 3.0% in the second quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock valued at $374,000 after buying an additional 111 shares during the last quarter. Sequoia Financial Advisors LLC boosted its holdings in Colgate-Palmolive by 0.6% in the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after acquiring an additional 113 shares in the last quarter. Finally, Evernest Financial Advisors LLC increased its holdings in shares of Colgate-Palmolive by 4.0% during the second quarter. Evernest Financial Advisors LLC now owns 2,985 shares of the company’s stock valued at $290,000 after acquiring an additional 115 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.